Groupe la Francaise Sells 17,378 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• Groupe la Francaise cut its Intuitive Surgical stake by 14.1% in the second quarter, selling 17,378 shares and retaining 105,842 shares valued at approximately $41.9 million.
• Intuitive Surgical reported quarterly EPS of $2.80, beating estimates by $0.32, while revenue reached $2.89 billion, up 18.4% year over year.
• Despite recent insider selling and a stock price of $366.70, analysts maintain a “Moderate Buy” consensus with an average target price of $508.68; institutional investors own 83.64% of the company.

Groupe la Francaise lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 14.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 105,842 shares of the medical equipment provider's stock after selling 17,378 shares during the quarter. Groupe la Francaise's holdings in Intuitive Surgical were worth $41,883,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in ISRG. Main Street Group LTD acquired a new stake in shares of Intuitive Surgical during the 1st quarter worth $30,000. Compass Financial Management LLC acquired a new position in Intuitive Surgical in the second quarter valued at about $30,000. Vermillion Wealth Management Inc. lifted its position in Intuitive Surgical by 58.1% during the first quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider's stock worth $31,000 after purchasing an additional 25 shares during the period. Motiv8 Investments LLC bought a new stake in Intuitive Surgical during the fourth quarter worth about $34,000. Finally, Evergreen Advisors LLC acquired a new stake in Intuitive Surgical during the first quarter worth about $35,000. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

ISRG opened at $366.70 on Monday. The company's 50 day moving average is $381.44 and its 200-day moving average is $428.20. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88. The company has a market cap of $129.55 billion, a P/E ratio of 42.00, a PEG ratio of 2.77 and a beta of 1.47.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.48 by $0.32. The business had revenue of $2.89 billion during the quarter, compared to analysts' expectations of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The firm's quarterly revenue was up 18.4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.81 EPS. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

Insider Activity at Intuitive Surgical

In related news, Director Amy Ladd sold 72 shares of the firm's stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $393.10, for a total transaction of $28,303.20. Following the sale, the director owned 179 shares of the company's stock, valued at $70,364.90. This trade represents a 28.69% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 77 shares of the business's stock in a transaction on Friday, August 21st. The stock was sold at an average price of $375.57, for a total value of $28,918.89. Following the sale, the executive vice president owned 881 shares in the company, valued at $330,877.17. This represents a 8.04% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 11,635 shares of company stock worth $4,640,172. Corporate insiders own 0.60% of the company's stock.

Wall Street Analyst Weigh In

ISRG has been the topic of several recent analyst reports. The Goldman Sachs Group set a $558.00 target price on shares of Intuitive Surgical in a report on Wednesday, May 27th. Sanford C. Bernstein reiterated an "outperform" rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. BNP Paribas Exane raised shares of Intuitive Surgical to an "outperform" rating in a research note on Tuesday, July 28th. Royal Bank Of Canada lowered their price objective on shares of Intuitive Surgical from $650.00 to $600.00 and set an "outperform" rating for the company in a research report on Monday, July 13th. Finally, JPMorgan Chase & Co. reduced their target price on Intuitive Surgical from $550.00 to $450.00 and set an "overweight" rating on the stock in a report on Friday, July 17th. Twenty-two equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $508.68.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.